The FINANCIAL -- The research-based pharmaceutical industry in Europe on April 7 welcomed the European Commission’s plans to reform rules on information provision to patients.
MoreThe FINANCIAL -- PSP Training Centre, founded by the leading pharmaceutical company, plans to cooperate with Russian specialists. The centre is expecting Mr. Andrey Manukhi, a specialist in pharmaceutical methodology.
MoreThe FINANCIAL -- Paata Kurtanidze, General Director of Aversi, one of the leading pharmaceutical companies in Georgia has denied reports by local media about rise of prices on medicines.
MoreThe FINANCIAL -- BRUSSELS, The European Commission has initiated infringement proceedings against Germany over its restrictions on the ownership of pharmacies, a spokeswoman said on February 1.
MoreThe FINANCIAL -- Bayer has been granted marketing approval of Nexavar in Japan for the treatment of advanced renall cell carcinoma (RCC), the most common form of kidney cancer.
MoreThe FINANCIAL -- “In the past pharmacies were associated with health care only, but today the situation has changed as pharmacies have become a part of people’s everyday lives. Pharmaceutical Company GPC is trying to develop this tendency and in the
MoreThe FINANCIAL -- Waterborne two-component polyurethane (PU) coatings are increasingly replacing solventborne systems. And for good reason: They are environment-friendly and satisfy statutory VOC guidelines intended to limit the emission of volatile organic compounds.
MoreThe FINANCIAL -- Effective January 1, 2008, Bayer MaterialScience is raising its sales prices for polyurethane systems for use in the automotive sector in the Europe, Middle East and Africa (EMEA) region by EUR 0.15 per kilogram.
MoreMajor Phase III Data Show Zevalin Significantly Increases Progression-Free Survival in Follicular Ly
The FINANCIAL -- Zevalin ([90Y]-ibritumomab tiuxetan) consolidation therapy significantly improves progression-free survival (PFS) rates in advanced stage follicular lymphoma (FL), according to major new data presented at the 49th Annual Meeting of the American Society of Hematology.
More